Scarica l'app Stockscreener
15.69
1.01%
-0.16
Dopo l'orario di chiusura:
15.53
-0.16
-1.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.85
Aprire:
$15.95
Volume 24 ore:
954.89K
Relative Volume:
0.58
Capitalizzazione di mercato:
$2.07B
Reddito:
$260.11M
Utile/perdita netta:
$60.64M
Rapporto P/E:
36.49
EPS:
0.43
Flusso di cassa netto:
$92.29M
1 W Prestazione:
+0.06%
1M Prestazione:
+2.21%
6M Prestazione:
+91.81%
1 anno Prestazione:
+67.45%
Intervallo 1D:
$15.63
$16.07
Intervallo di 1 settimana:
$15.15
$16.07
Portata 52W:
$6.55
$16.48
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Confronta AUPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
15.69 | 2.09B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-11-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-05 | Iniziato | Cowen | Outperform |
| 2020-01-10 | Iniziato | Jefferies | Buy |
| 2019-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Reiterato | FBR & Co. | Outperform |
| 2016-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum - Yahoo Finance
How (AUPH) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC - MarketBeat
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Yahoo Finance
Earnings Report: Can Aurinia Pharmaceuticals Inc stock deliver 10 annual returns2025 AllTime Highs & Long-Term Safe Investment Ideas - moha.gov.vn
State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - sharewise.com
Will Aurinia Pharmaceuticals Inc. (IKAP) stock return to pre crash levelsWeekly Trade Report & Low Risk Entry Point Guides - Newser
Can Aurinia Pharmaceuticals Inc. stock weather global recessionWeekly Trade Review & Detailed Earnings Play Alerts - Newser
How Aurinia Pharmaceuticals Inc. (IKAP) stock valuation compares with sectorJuly 2025 Action & High Accuracy Trade Signal Alerts - Newser
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 5.2%Time to Sell? - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs - MarketBeat
Can Aurinia Pharmaceuticals Inc. stock surprise with earnings upsideStock Surge & Reliable Price Breakout Signals - Newser
Aurinia Pharmaceuticals Shares Fall After Leerink Partners Downgrade - marketscreener.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛
Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns - Investing.com Canada
Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $16 From $15 - marketscreener.com
Will Aurinia Pharmaceuticals Inc. stock sustain high P E ratios2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Defamation Litigation Roundup: FDA, Lively, Alexander Bros. - Law360
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance
Trading Systems Reacting to (AUPH) Volatility - news.stocktradersdaily.com
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com
Will Aurinia Pharmaceuticals Inc. (IKAP) stock test record highs in 2025Analyst Downgrade & Weekly Setup with ROI Potential - Newser
Aurinia Pharmaceuticals Inc $AUPH Stake Trimmed by Geode Capital Management LLC - MarketBeat
What earnings margins imply for Aurinia Pharmaceuticals Inc. (IKAP) stock2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is Aurinia Pharmaceuticals Still a Good Value After 83.8% YTD Surge? - Yahoo Finance
A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Yahoo Finance
Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
How Aurinia Pharmaceuticals Inc. (IKAP) stock trades pre earningsEarnings Performance Report & Trade Opportunity Analysis - BỘ NỘI VỤ
Why retail investors favor Aurinia Pharmaceuticals Inc. stockJuly 2025 Review & Community Driven Trade Alerts - moha.gov.vn
Advantage Alpha Capital Partners LP Takes $204,000 Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Segall Bryant & Hamill LLC Sells 221,933 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Aurinia Pharmaceuticals Inc $AUPH Shares Bought by SG Americas Securities LLC - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month HighHere's Why - MarketBeat
Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - sharewise.com
[Form 4] Aurinia Pharmaceuticals Inc. Insider Trading Activity - Stock Titan
Dir Bailey Surrenders 2,716 Of Aurinia Pharmaceuticals Inc [AUPH] - TradingView
Aurinia Pharmaceuticals Inc. (IKAP.F) stock price, news, quote and history - Yahoo Finance UK
Aurinia Pharmaceuticals stock hits 52-week high at $16.20 By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals stock hits 52-week high at $16.20 - Investing.com India
First Week of AUPH July 2026 Options Trading - Nasdaq
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):